scholarly journals Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs

2016 ◽  
Author(s):  
F Lamine ◽  
F Lalubin ◽  
N Pitteloud ◽  
M Burnier ◽  
A Zanchi
Keyword(s):  
Primary Care ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Primary Care Physicians ◽  
Antidiabetic Drugs ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

scholarly journals MO235EFFECT OF OMEGA-3 POLYUNSATURATED FATTY ACID SUPPLEMENTATION ON GLYSEMIC CONTROL AND RENAL FUNCTION IN TYPE 2 DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Mehmet Usta ◽  
Alpaslan Ersoy ◽  
Canan Ersoy ◽  
Yavuz Ayar ◽  
Gultekin Goksel ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Renal Function ◽  
Kidney Disease ◽  
Diabetic Patients ◽  
Omega 3 ◽  
Short Term ◽  
Type 2 Diabetic Patients ◽  
Pufa Supplementation ◽  
Type 2 Diabetic

Abstract Background and Aims The aim of this study was to evaluate the short-term effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) supplementation on glycemic control and renal function in type 2 diabetic patients with chronic kidney disease. Method Twenty-five diabetic patients received medication containing 2 g/day n-3 PUFA orally in addition to standard treatments. Their estimated glomerular filtration rates (eGFR) were <80 mL/min/1.73 m2. Biochemical values were evaluated before and 3 months after treatment. Results After three months of supplementation, the changes in serum creatinine, uric acid, eGFR and urinary albumin excretion levels did not reach statistical significance. There was no difference between serum glucose, HbA1C and lipid profile values before and after the n-3 PUFA supplementation in patients. Only serum albumin significantly increased from 4.10±0.26 to 4.28±0.31 g/dL (p=0.016), and systolic blood pressure decreased from 121.4±14.5 to 116.6±14.9 mmHg (p=0.001). Conclusion Short-term n-3 PUFA supplementation did not affect renal function and glycemic control in patients with type 2 diabetes with chronic kidney disease.

Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients

2018 ◽  
Vol 186 (2) ◽  
pp. 330-336 ◽  
Author(s):  
Ching-Chiang Lin ◽  
Ching-Tang Shih ◽  
Chien-Hung Lee ◽  
Yeou-Lih Huang
Keyword(s):  
Chronic Kidney Disease ◽  
Trace Elements ◽  
Kidney Disease ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Early Stages ◽  
Type 2 Diabetic

Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease

2015 ◽  
Vol 87 (6) ◽  
pp. 45 ◽  
Author(s):  
V. I. Konenkov ◽  
V. V. Klimontov ◽  
N. E. Myakina ◽  
N. V. Tyan ◽  
O. N. Fazullina ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Inflammatory Cytokines ◽  
Diabetic Patients ◽  
Serum Concentrations ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

scholarly journals Low Ankle-Brachial Index Is Associated with Early-Stage Chronic Kidney Disease in Type 2 Diabetic Patients Independent of Albuminuria

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e109641 ◽  
Author(s):  
Xuehong Dong ◽  
Dingting Wu ◽  
Chengfang Jia ◽  
Yu Ruan ◽  
Xiaocheng Feng ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Early Stage ◽  
Ankle Brachial Index ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document